July 23, 2014 1:50 PM ET


Company Overview of Copernicus Therapeutics, Inc.

Company Overview

Copernicus Therapeutics, Inc., a biotechnology company, develops non-viral delivery systems for the non-toxic delivery of nucleic acid drugs. Its products are used to treat cystic fibrosis, retinitis pigmentosa, macular degeneration, diabetic retinopathy, Parkinson’s diseases, other CNS diseases, and cancer. Copernicus Therapeutics, Inc. was formerly known as Copernicus Gene Systems, Inc. and changed its name to Copernicus Therapeutics, Inc. in 1999. The company was founded in 1995 and is based in Cleveland, Ohio.

11000 Cedar Avenue

Suite 145

Cleveland, OH 44106-3052

United States

Founded in 1995





Key Executives for Copernicus Therapeutics, Inc.

Chief Executive Officer and President
Co-Founder and Senior Vice President of Science & Medical Affairs
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
NaniRx Therapeutics, Inc. United States
Cytopeia, Inc. United States
Smart Biosciences, Inc. United States
Deltagen Research Laboratories, L.L.C. United States
AMPRO Products, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Copernicus Therapeutics, Inc., please visit www.cgsys.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.